| Literature DB >> 27887661 |
Anna Marco-Ramell1,2, Laura Arroyo1, Raquel Peña1,3, Raquel Pato1,3, Yolanda Saco1,3, Lorenzo Fraile4,5, Emøke Bendixen6, Anna Bassols7,8.
Abstract
BACKGROUND: The objective assessment of animal stress and welfare requires proper laboratory biomarkers. In this work, we have analyzed the changes in serum composition in gilts after switching their housing, from pen to individual stalls, which is generally accepted to cause animal discomfort.Entities:
Keywords: Acute phase proteins; Biomarker; Individual confinement; Innate immunity; Lipids; Oxidative stress; Pig; Proteomics; Stress
Mesh:
Substances:
Year: 2016 PMID: 27887661 PMCID: PMC5124275 DOI: 10.1186/s12917-016-0887-1
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Calculated composition of the diets for gilts allocated in pen or individual stalls based on its feed composition and its average daily feed in each case
| Diet | Pen | Individual stalls |
|---|---|---|
| DM, g/Kg | 896 | 900.7 |
| DM basis, g/Kg | ||
| Protein | 158 | 135 |
| Fat | 65 | 49.3 |
| Crude fiber | 53 | 91.8 |
| Ash | 60 | 69.6 |
| Nitrogen free extract | 560 | 555 |
| ME, MJ/kg | 12.8 | 11.5 |
| Feed intake, Kg DM/day | 2.5 | 2.5 |
| ME intake, MJ/day | 32 | 29 |
List of analytical methods
| Biochemical parameter | Sample type | Method | Manufacturer |
|---|---|---|---|
| NEFAs | Serum | NEFA-C reagent | Wako Chemicals GmbH (Neuss, Germany) |
| Cholesterol | Serum | CHOP-PAP-method | Olympus System Reagents (OSR) -Olympus Diagnostica GmbH |
| Triglycerides | Serum | GPO-PAP method | OSR |
| Urea | Serum | GLDH method | OSR |
| Creatinine | Serum | Jaffé method | OSR |
| Total protein | Serum | Biuret method | OSR |
| Creatine kinase (CK) | Serum | IFCC method | OSR |
| Alanine aminotransferase (ALT) | Serum | IFCC method, without pyridoxal phospate | OSR |
| Alkaline phosphatase (ALP) | Serum | IFCC method | OSR |
| Haptoglobin | Serum | Phase Haptoglobin kit (colorimetric assay | Tridelta Ltd (County Kildare, Ireland) |
| C-reactive protein (CRP)a | Serum | Immunoturbidimetric method | OSR (#6147) |
| Pig-MAP | Serum | ELISA | PigChamp ProEuropa (Segovia, Spain) |
| Cortisol | Serum | ELISA | DRG Diagnostics (Marburg, Germany) |
| Cortisol | Saliva | ELISA | DRG Diagnostics |
| Glutathione peroxidase (GPx) | Erythrocyte lysate | Cumene Hydroperoxide (Ransel) | Randox Laboratories Ltd |
| Superoxide dismutase (SOD) | Erythrocyte lysate | Xanthine oxidase (Ransod) | Randox Laboratories Ltd |
| Total glutathione (tGSH) | Deproteinized blood | Glutathione Assay | Northwest (Vancouver, WA) |
aValidated for porcine samples [42]
Serum concentration of compounds related to lipid and protein metabolism, enzyme activities and cortisol in serum and saliva in the HS and the H group throughout the experimental period (mean ± SD)
| Parameter | D1 | D3 | D4 | D5 | Group |
|---|---|---|---|---|---|
| NEFAs, mmol/L | 0.08 ± 0.06 | 0.13 ± 0.58* | 0.08 ± 0.04 | 0.04 ± 0.01b | H |
| 0.14 ± 0.04** | 0.09 ± 0.06 | 0.08 ± 0.04a | HS | ||
| Triglycerides, mg/dL | 49 ± 18 | 48 ± 15 | 64 ± 20* | 70 ± 23** | H |
| 53 ± 16 | 58 ± 21 | 85 ± 29** | HS | ||
| Total cholesterol, mg/dL | 101 ± 18 | 116 ± 63 | 93 ± 11 | 99 ± 29 | H |
| 138 ± 46* | 94 ± 17 | 114 ± 39 | HS | ||
| Urea, mg/dL | 31.4 ± 5.5 | 36.4 ± 5.2* | 25.1 ± 4.7** | 24.0 ± 3.4*** | H |
| 32.3 ± 10.3* | 22.5 ± 3.6*** | 22.7 ± 4.1*** | HS | ||
| Creatinine, mg/dL | 1.66 ± 0.22 | 1.96 ± 0.31** | 1.84 ± 0.20*a | 1.90 ± 0.25* | H |
| 1.91 ± 0.28* | 1.64 ± 0.19b | 1.82 ± 0.43 | HS | ||
| Total protein, g/dL | 7.66 ± 0.32 | 8.11 ± 0.58* | 8.14 ± 0.41**a | 7.97 ± 0.31* | H |
| 7.86 ± 0.38 | 7.85 ± 0.36b | 7.75 ± 0.42 | HS | ||
| CK, U/mL | 7.85 ± 16.25 | 10.22 ± 13.32b | 10.66 ± 28.46 | 2.98 ± 3.58 | H |
| 90.14 ± 125.14*a | 11.96 ± 21.39 | 38.90 ± 65.58 | HS | ||
| ALT, U/L | 65.4 ± 126.6 | 97.1 ± 125.0 | 63.3 ± 37.1 | 62.4 ± 22.4 | H |
| 125.6 ± 95.6* | 65.1 ± 11.5 | 72.9 ± 19.6 | HS | ||
| ALP, U/L | 104.7 ± 31.2 | 134.9 ± 60.3 | 100.3 ± 22.3 | 116.6 ± 26.2 | H |
| 107.6 ± 42.8 | 105.4 ± 32.3 | 98.3 ± 31.3 | HS | ||
| Serum cortisol, μg/dL | 8.47 ± 4.92 | 5.56 ± 2.86 | 7.02 ± 4.93 | 5.08 ± 4.17* | H |
| 7.22 ± 6.08 | 6.32 ± 4.79 | 6.49 ± 5.10 | HS | ||
| Salivary cortisol, ng/mL | 6.53 ± 4.69 | 9.88 ± 6.96 | 9.80 ± 6.01* | 11.29 ± 6.33** | H |
| 25.01 ± 42.28 | 14.54 ± 12.36* | 12.02 ± 9.88** | HS |
a,b Within columns, means with a different superscript differed significantly (P < 0.05) between H and HS group
Asterisks show significant differences versus D1: *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 1Average serum concentrations of acute phase proteins in H and HS groups throughout the trial. Asterisks represent statistically significant differences between D3, D4 or D5 and basal levels (D1): *P < 0.05, **P < 0.01, ***P < 0.001. Different letter means significant differences between H and HS groups (P < 0.05)
Fig. 2Average serum concentrations of oxidative stress markers in H and HS groups throughout the trial. Asterisks represent statistically significant differences between D3, D4 or D5 and basal levels (D1): *P < 0.05, **P < 0.01, ***P < 0.001. Different letter means significant differences between H and HS groups (P < 0.05)
Selected differentially expressed proteins at D3 and D5 versus D1 (basal levels) in the H and HS groups identified by proteomics (DIGE or iTRAQ)
| Protein | Technique | Day 3 | Day 5 | ||
|---|---|---|---|---|---|
| FC H | FC HS | FC H | FC HS | ||
| Immune system | |||||
| Alpha-1- antichymotrypsin 3 | DIGE | 1.74 | 1.20 | 1.36 | 1.16 |
| Galectin-1 | iTRAQ | 1.64 | 2.31 | 1.08 | 2.56 |
| Haptoglobin (spot 1) | DIGE | 3.24 | 2.19 | 1.71 | 1.63 |
| Haptoglobin (spot 2) | DIGE | 1.48 | 1.73 | 1.29 | 1.34 |
| Lactotransferrin | iTRAQ | 1.21 | 1.38 | 1.54 | 1.08 |
| Protegrin-3 | iTRAQ | 1.45 | 1.75 | 1.46 | 1.69 |
| Transport | |||||
| Apolipoprotein A-I | DIGE | −1.38 | −1.70 | −1.26 | −1.53 |
| Apolipoprotein A-I | iTRAQ | −1.28 | −1.62 | −1.04 | −1.64 |
| Apolipoprotein E | iTRAQ | −1.89 | −1.96 | −1.22 | −1.60 |
| Apolipoprotein C-III | iTRAQ | −1.56 | −1.79 | −1.18 | −1.72 |
| Apolipoprotein R | iTRAQ | −1.36 | −1.78 | −1.03 | −1.73 |
| Apolipoprotein M | iTRAQ | −1.49 | −1.80 | −1.26 | −2.02 |
| Antioxidant defenses | |||||
| Glutathione peroxidase 3 | iTRAQ | −1.45 | −1.58 | −1.06 | −1.51 |
| Peroxiredoxin 2 | DIGE | 3.73 | 5.78 | 2.09 | 4.86 |
| Peroxiredoxin 2 | iTRAQ | 1.99 | 2.31 | 1.80 | 2.17 |
Increased proteins at D3 are represented as positive fold-changes (FC) and decreased proteins as negative FC. Proteins are classified according to their biological function. The complete list of differentially expressed proteins identified by MS is shown in Additional file 1 (DIGE) and Additional file 2 (iTRAQ)
Fig. 3Serum proteome analysis by DIGE. Representative image of one of the four 2D gels containing 150 μg protein (50 μg prot/condition) and stained with Flamingo® (Bio-Rad). Differentially expressed spots identified by MS are marked